Table 2.
Strains and plasmids | Genotype and relevant characteristics* | Reference or source |
---|---|---|
Strains | ||
P. protegens | ||
LK099 | Wild-type Pf-5 | (Howell and Stipanovic, 1979) |
JL4928 | ΔpltAΔphlD | This study |
LK269 | ΔpltAΔphlDΔpltR | This study |
LK270 | ΔpltM | This study |
LK024 | ΔphlD | (Kidarsa et al., 2011) |
LK293 | ΔpltMΔpltR | This study |
LK397 | ΔphlDΔpltM | This study |
LK096 | ΔpltAΔphlA | (Henkels et al., 2014) |
LK403 | ΔphlAΔpltM | This study |
LK413 | ΔphlAΔphlDΔpltA | This study |
P. fluorescens SBW25 | SBW25 is a member of the P. fluorescens group but does not contain the phl or plt gene clusters | (Silby et al., 2009) |
E. coli | ||
BL21(DE3) | ompT hsdSB (rB−mB−) gal dcm | NEB |
S17-1 | recA pro hsdR-M+ RP4 2-Tc::Mu-Km::Tn7 Smr Tpr | (Simon et al., 1983) |
Plasmids | ||
pEX18Tc | Gene replacement vector with MCS from pUC18, sacB+ Tcr | (Hoang et al., 1998) |
p18Tc-ΔpltM | pEX18Tc containing pltM with an internal deletion of 1345 bp | This study |
pPROBE-NT | pBBR1 containing promoterless gfp, Kmr | (Miller et al., 2000) |
pRL-gfp | pPROBE-NT containing pltR as well as the intergenic region between pltR and pltL including the promoter of pltL fused with a promoterless gfp | This study |
pMRL-gfp | pPROBE-NT containing pltM and pltR as well as the intergenic region between pltR and pltL including the promoter of pltL fused with a promoterless gfp | This study |
pL-gfp | Called ppltL-gfp previously. Contains the intergenic region between pltR and pltL including the promoter of pltL fused with a promoterless gfp | (Yan et al., 2016) |
pME6010 | pACYC177-pVS1 shuttle vector, Tcr | (Heeb et al., 2000) |
pME6010-pltM | pME6010 containing pltM, which is expressed from the constitutive promoter Pk | This study |
pET28a(+) | Protein overexpression vector | Novagen |
pET28a-PltM | pET28a containing pltM, used for overexpression of the PltM protein | This study |
pET28a-SsuE | pET28a containing ssuE, used for overexpression of the SsuE protein | This study |
*Smr, streptomycin resistance; Tpr, trimethoprim resistance; Tcr, tetracycline resistance; Kmr, kanamycin resistance.